LARCHER, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 300
EU - Europa 251
NA - Nord America 224
SA - Sud America 60
Totale 835
Nazione #
US - Stati Uniti d'America 216
SG - Singapore 127
IT - Italia 90
CN - Cina 75
HK - Hong Kong 73
BR - Brasile 54
DE - Germania 50
SE - Svezia 29
NL - Olanda 20
FI - Finlandia 16
RU - Federazione Russa 15
IN - India 12
GB - Regno Unito 8
IE - Irlanda 8
CA - Canada 6
AT - Austria 5
KR - Corea 5
BE - Belgio 4
AR - Argentina 2
ID - Indonesia 2
PY - Paraguay 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
EC - Ecuador 1
GT - Guatemala 1
IQ - Iraq 1
LT - Lituania 1
MX - Messico 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 835
Città #
Hong Kong 72
Singapore 50
New York 36
Shanghai 34
Milan 33
Ashburn 32
Boardman 15
Munich 13
Nuremberg 11
Rome 11
Falkenstein 10
Dallas 8
Dublin 8
Turku 8
Pune 7
Amsterdam 6
Frankfurt am Main 6
Turin 6
Helsinki 5
Lawrence 5
London 5
Los Angeles 5
Moscow 5
Princeton 5
The Dalles 5
Beijing 4
Brussels 4
Seattle 4
Toronto 4
Hyderabad 3
Lappeenranta 3
Pisa 3
Pyeongtaek-si 3
Taizhou 3
Vienna 3
Washington 3
Betim 2
Buffalo 2
Cancello e Arnone 2
Canoas 2
Chaam 2
Cortona 2
Guangzhou 2
Lissone 2
Miami 2
Osio Sotto 2
Phoenix 2
Rio de Janeiro 2
Shenzhen 2
Ufa 2
Yogyakarta 2
Yongin-si 2
Ajman 1
Anápolis 1
Araxá 1
Assis 1
Asunción 1
Belo Horizonte 1
Bergamo 1
Birmingham 1
Blumenau 1
Boituva 1
Borås 1
Botucatu 1
Bragança Paulista 1
Brooklyn 1
Busto Garolfo 1
Campinas 1
Capão do Leão 1
Caraguatatuba 1
Castro 1
Chicago 1
Ciudad del Este 1
Cologno Monzese 1
Contagem 1
Cáceres 1
Dourados 1
Dracena 1
Dushanbe 1
Erbil 1
Ferrara 1
Florence 1
Forio 1
Friesland 1
General Salgado 1
Geneva 1
Goiânia 1
Groningen 1
Guatemala City 1
Gunzenhausen 1
Hillsboro 1
Horizonte 1
Itumbiara 1
Japeri 1
Jardim 1
Joinville 1
Karachi 1
Laredo 1
Lençóis Paulista 1
Lima 1
Totale 518
Nome #
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 52
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 48
Von Hippel-Lindau disease-associated renal cell carcinoma: a call to action 47
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 43
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 43
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 41
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 40
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 40
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease 38
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 36
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 36
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 35
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 34
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 32
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 31
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 28
Influences of Age and Comorbidities on Indication for Partial Nephrectomy: A Systematic Review 28
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 27
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 25
Pulmonary lesion after surgery for renal cancer: progression or new primary? 24
The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis 24
Recurrent pregnancy loss: a male crucial factor—A systematic review and meta‐analysis 23
Biological characterization of renal masses using immuno-PET 23
Technical and Functional Validation of a Teleoperated Multirobots Platform for Minimally Invasive Surgery 19
Enhancing surgical process modeling for artificial intelligence development in robotics: The saras case study for minimally invasive procedures 19
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 17
To clamp or not to clamp? A step back to go forward 13
RADIOMIC AND GENOMIC APPROACHES FOR THE ENHANCED DIAGNOSIS OF RENAL CANCER (REDIRECT): A TRANSLATIONAL PILOT STUDY 12
Reply to Angela Estevez, Phillip Kim, Peter Chang, and Andrew A. Wagner's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol 2024;85:63–71 11
Reply to Jared P. Schober, Robert Wang, and Alexander Kutikov's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol. 2023;85:63–71 10
Totale 899
Categoria #
all - tutte 7.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.085


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 0 0 0 0 1 0 1 0 5
2022/202368 11 9 4 4 4 8 4 8 2 2 1 11
2023/2024220 14 9 20 13 14 46 1 36 5 6 15 41
2024/2025604 54 17 35 49 45 40 89 64 88 34 39 50
Totale 899